South Africa has a high rate of HIV and hepatitis B co-infection. The national HIV treatment guidelines include anti-retrovirals that treat both viruses. We describe a HIV-positive patient who presented with liver histology-confirmed hepatitis B immune reconstitution inflammatory syndrome whilst on a regimen containing lamivudine and tenofovir.
FirnharberC. The prevalence of hepatitis B co-infection in a South African urban government HIV clinic. S Afr Med J2008; 98: 541–544.
2.
HoffmanCJ. Hepatoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B. AIDS2007; 21: 1301–1308.
3.
ChangJLewisSR. Immunopathogenesis of hepatitis B virus infection. Immunol Cell Biol2007; 85: 16–23.
4.
ColinJFCazals-HatemD. Influence of HIV infection on chronic hepatitis B in homosexual men. Hepatology1999; 29: 1306–1310.
5.
Expert Committee. Management of HIV-hepatitis B co-infection. South Afr J HIV Med 2011; April: 27–36.
6.
AvihingsanonA. Assessment of HBV flare in a randomised clinical trial in HIV/HBV co-infected subjects initiating HBV active antiretroviral therapy in Thailand. AIDS Res Chemother2012; 9: 6–6.
7.
Drake A, Mijich A and Sasadeusz J. Immune reconstitution hepatitis in HIV and hepatitis B coinfection, despite lamivudine therapy as part of HAART. CID 2004; July: 129–132.
